SEC Form 4 · accession 0001654954-18-003327
MusclePharm Corp · MSLP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John J Desmond
Director
Period of report
Jul 24, 2017
Accepted (ET)
Mar 29, 2018 · 9:30 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415684
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 24, 2017 | A | 80,214 | $0.00 | A | 80,214 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of restricted stock vesting in four equal installments each quarter over the next year.